AMCP 2022

Shahnaz Khan, MPH, Executive Director of Market Access and Outcomes Strategy, will be attending AMCP 2022. Connect with her to learn more about how we can help you with your drug or medical device development.

Share on: 

Research coauthored by RTI Health Solutions researcher Bradley Layton will be presented at AMCP 2022.

Immunoglobulin initiation among patients with primary immunodeficiency diseases: a retrospective claims-based United States cohort study.Anderson-Smits C, Orange J, Park M, Huang Z, Layton JB, Ritchey ME.